Daniel Freedman Joins Quantum X Labs as Distinguished Quantum Scientist
THE SO WHAT
Top-tier theoretical talent like Freedman joining a commercial lab is another data point that quantum IP is consolidating inside venture-backed and public companies, not just universities. For enterprises, that means more chances to co-develop domain-specific algorithms with vendors—but also a faster-moving proprietary landscape to track in partnership decisions.
READ THE SOURCE
MORE FROM THE WIRE
Deep & Emerging TechIntel’s stock is rising as the company looks primed to boost prices even more
If Intel can push through another round of PC chip price hikes on top of rising supply-chain costs, the real squeeze lands on OEM margins and end-user device pricing. For IT buyers, multi-vendor CPU strategies and extended refresh cycles become a straightforward cost-control lever.
Deep & Emerging TechProton VPN sign-ups soar in Vietnam as stringent new cyberlaw takes effect
A 450% spike in Proton VPN sign-ups after Vietnam’s new cyberlaw shows how quickly policy can reroute traffic through privacy tools. If you operate consumer or data-heavy services in similar jurisdictions, model VPN-heavy usage as a default, not an edge case.
Deep & Emerging TechKeep hackers out of your WhatsApp account with these 3 steps
WhatsApp’s stronger passkeys and 2FA don’t matter if users ignore them — account takeover is still a human-process problem. If your org relies on WhatsApp for any critical coordination, treat security setup as an onboarding requirement, not a user suggestion.
Deep & Emerging TechGoogle DeepMind releases AlphaGenome Atlas, a 1PB dataset of predicted molecular effects for all ~9B possible single-letter DNA changes in the human genome
A 1 PB AlphaGenome Atlas covering ~9B single-letter DNA changes compresses years of wet-lab exploration into queryable infrastructure. If you’re in drug discovery or diagnostics, your bottleneck shifts from data generation to hypothesis selection and validation pipeline throughput.